PCVX: Vaxcyte Inc

PCVX新闻

• 17:00 Jefferies重申Vaxcyte股票买入评级,监管标准明朗化
• 16:59 Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity
• 20:18 BTIG上调Vaxcyte目标价至89美元,看好其疫苗覆盖范围优势
• 20:17 BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
• 12:14 Leerink上调Vaxcyte股票目标价,看好疫苗管线扩张
• 12:12 Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
• 04:27 Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
• 13:36 Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
• 21:19 Vaxcyte完成6.325亿美元普通股公开发行
• 21:17 Vaxcyte closes $632.5 million public offering of common stock
• 04:38 Vaxcyte定价5.5亿美元普通股公开发行
• 04:37 Vaxcyte prices $550 million public offering of common stock
• 03:30 Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
• 21:15 Vaxcyte启动5亿美元普通股公开发行
• 21:13 Vaxcyte launches $500 million public offering of common stock
• 14:19 LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
• 13:08 Cantor Fitzgerald reiterates Overweight rating on Vaxcyte stock
• 10:12 Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Vaxcyte (NASDAQ:PCVX)